Jennison Associates LLC Puma Biotechnology, Inc. Transaction History

Jennison Associates LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 06, 2019	SELL	$20.07 - $46.7 $9.8 Million - $22.8 Million	-488,418 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$41.2 - $59.85 $19.1 Million - $27.7 Million	-462,580 Reduced 48.64%	488,418 $22.4 Million
Q2 2018 Aug 02, 2018	BUY	$48.3 - $68.25 $22.5 Million - $31.8 Million	465,453 Added 95.86%	950,998 $56.3 Million
Q1 2018 Apr 20, 2018	BUY	$59.7 - $99.25 $29 Million - $48.2 Million	485,545 New	485,545 $33 Million

101

29M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $136M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.